Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000866850 | SCV001008002 | likely benign | Cowden syndrome 6 | 2023-11-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002434094 | SCV002750089 | likely benign | Inborn genetic diseases | 2022-02-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003396510 | SCV004135307 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | AKT1: BP4, BP7 |
Prevention |
RCV004745624 | SCV005367316 | likely benign | AKT1-related disorder | 2019-08-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |